
Pharmaceutical products for Gerencia de la Fundación Marqués de Valdecilla
Resolved
- Supplies
- Cantabria, ES
- FMV/BSTC/CB 01/2025
Amount
Tender for Contrato basado en el acuerdo marco del INGESA ((2024/049) para el suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial de plasma humano proveniente del sistema nacional de salud, con destino al Banco de Sangre y Tejidos de Cantabria / Fundación Marqués de Valdecilla. Fraccionamiento plasma FMV/BSTC/CB 01/2025.
The tender identified with expedient FMV/BSTC/CB 01/2025 is related to the sector Supplies. This tender, published on January 21, 1970 and last updated on January 21, 1970, aims to Contrato basado en el acuerdo marco del INGESA ((2024/049) para el suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial de plasma humano proveniente del sistema nacional de salud, con destino al Banco de Sangre y Tejidos de Cantabria / Fundación Marqués de Valdecilla. Fraccionamiento plasma FMV/BSTC/CB 01/2025.. The estimated value of the contract is €1,282,100.00 , with a budget excluding taxes of €1,282,100.00 . The procedure modality is Open, and currently its status is Resolved.
This tender is located in Cantabria, ES, Cantabria, ES. The main source of this information is Plataforma de Contratación del Sector Público .
The tender is classified under several CPV codes, including CPV, among others Pharmaceutical products (No code: 33600000), Plasma extracts (No code: 33141520), among others.
Gerencia de la Fundación Marqués de Valdecilla
Total tenders
118
Active tenders
0
Total awards
115
Related Organizations
63
Award criteria
Documents
Location:
Cantabria, ESStatus
ResolvedProcedure
OpenContract type
SuppliesPublication date
January 21, 1970Budget excluding taxes
€1,282,100.00Estimated contract value
€1,282,100.00Deadline
-Contract duration
17 monthsExtension
-Guarantee
Definitiva: 5%